
The company claims that this is the second inhalation product by Lupin Healthcare for the UK market after Luforbec pressurised…
The data analytics company said that the FDA and EMA generally approve more injectable drugs developed by large (market cap…
Pfizer’s shot is designed to target two strains of the respiratory virus. The company has so far enrolled about 37,000…
The company stated that following the completion of the clinical trial and receipt of marketing authorization from PMDA in Japan,…
The pharma major also informed that the standalone Sandoz would be headquartered in Switzerland and listed on the SIX Swiss…
The company claims that the penetration of generics is high in Japan as greying population is inclined to self-medicate to…
Precision oncology is based on using an individual’s genetic profile to make the best therapeutic choice and will help to…
Reportedly, the scrip was sold at 109.88 yuan apiece in an initial public offering that raised 11 billion yuan ($1.6…
According to the company’s press statement, the approval was based on results from the OlympiA Phase III trial, which suggested…
Myelofibrosis is a rare blood cancer that results from dysregulated JAK-signal transducer and activator of transcription protein signalling and is…
Lennox-Gastaut syndrome is a severe form of epilepsy that begins during childhood and causes several types of seizures, behavioral disturbances,…
According to experts, the most notable effect of the lack of any workable regulatory framework or standards is the accessibility…
No unexpected safety signals were observed and the findings from the trial will be presented at an upcoming medical meeting,…
Over the decades, the country’s pharmaceutical industry has made of capable of producing all types of drugs, including vitamins, antibiotics,…
Driving awareness and expanding access to treatment requires collaboration amongst multiple public and private stakeholders, Gupta told Financial Express.com.
The drug was marketed by GSK between 1995 and 1998, by Pfizer from 2000 to 2006, by Johnson & Johnson…
India is one of the strongest generic producers of antiretroviral, given the prevalence of HIV/ AIDS in the country. Generics…
According to reports, the demand for its vaccine is also waning in the United States, where it was authorised for…